Notes to Condensed Consolidated Financial Statements
NOTE 1—ORGANIZATION AND DESCRIPTION OF BUSINESS
Overview
Resonant Inc. is a late-stage development company located in Goleta, California. We were incorporated in Delaware in January 2012 as a wholly owned subsidiary of Superconductor Technologies Inc., or STI. Resonant LLC, a limited liability company, was formed in California in May 2012. We changed our form of ownership from a limited liability company to a corporation in an exchange transaction in June 2013, when we commenced business. We are the successor of Resonant LLC. We completed our initial public offering, or IPO, on May 29, 2014. On July 6, 2016 we acquired all of the issued and outstanding capital stock of GVR Trade S.A, or GVR. GVR is a wholly owned subsidiary of Resonant Inc.
We have created an innovative software, intellectual property, or IP, and services platform that we believe has the ability to increase designer efficiency, reduce the time to market and lower unit costs in the designs of filters for radio frequency, or RF, front-ends for the mobile device industry. The RF front-end, or RFFE, is the circuitry in a mobile device responsible for analog signal processing and is located between the device’s antenna and its digital circuitry. The software platform we continue to develop is based on fundamentally new technology that we call Infinite Synthesized Networks
®
, or ISN
®
, to configure and connect resonators, the building blocks of RF filters. Filters are a critical component of the RF front-end used to select desired radio frequency signals and reject unwanted signals.
We believe licensing our designs is the most direct and effective means of validating our ISN
®
platform and related IP libraries. Our target customers make part or all of the RFFE. We intend to retain ownership of our designs, and we expect to be compensated through license fees and royalties based on sales of RFFE filters that incorporate our designs.
Capital Resources and Liquidity
We use the net proceeds from the sales of our common stock for product development to commercialize our technology, research and development, the development of our patent strategy and expansion of our patent portfolio, as well as for working capital and other general corporate purposes.
We have earned minimal revenues since inception, and our operations have been funded with initial capital contributions and proceeds from the sale of equity securities and debt. At
June 30, 2019
and
December 31, 2018
, we had incurred accumulated losses of
$107.2 million
and
$92.6 million
, respectively. The losses are primarily the result of research and development costs associated with commercializing our technology, combined with start-up, financing and public company costs. We expect to continue to incur substantial costs as we continue to engage customers, increase the number of devices under design and build the infrastructure to support our anticipated growth.
Our condensed consolidated financial statements account for the continuation of our business as a going concern. We are subject to the risks and uncertainties associated with a new business. Our principal sources of liquidity as of
June 30, 2019
consist of existing cash, cash equivalents and investments totaling
$10.5 million
. In
July
and
August
2019, we entered into a securities purchase agreement with investors to raise gross proceeds of approximately
$10.0 million
in a private placement of common stock. The offering is expected to have multiple closings, with the initial closing for approximately
$3.0 million
to occur on or about
August 12, 2019
and closing for the balance of the funds expected to occur in the
fourth
quarter of 2019, subject to satisfaction of closing conditions. In the first half of 2019, we used approximately
$12.1 million
of cash and investments for operating activities, the purchase of property and equipment, and expenditures for patents. Due to these conditions, along with anticipated increases in expenses, substantial doubt exists as to our ability to continue as a going concern. After evaluation of these conditions, we believe our current resources, along with the expected proceeds from our private placement of common stock and forecasted billings, will provide sufficient funding for planned operations through the second quarter of 2020. If necessary, we will seek to raise additional capital from the sale of equity securities or the incurrence of indebtedness to allow us to continue operations. There can be no assurance that additional financing will be available to us on acceptable terms, or at all. Additionally, if we issue additional equity securities to raise funds, whether to existing investors or others, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. Additionally, we may be limited as to the amount of funds we can raise pursuant to SEC rules and the continued listing requirements of NASDAQ. If we cannot raise needed funds, we might be forced to make substantial reductions in our operating expenses, which could adversely affect our ability to implement our business plan and ultimately our viability as a company. These condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.
We have a Form S-3 universal shelf registration statement on file with the SEC. The universal shelf registration statement on Form S-3 permits us to sell, in one or more public offerings, shares of our common stock, shares of preferred stock or debt securities, or any combination of such securities and warrants to purchase securities, for proceeds in an aggregate amount of up to
$50.0 million
, subject to potential limitations on the amount of securities we may sell in any twelve-month period. The Form S-3 will expire in November 2021.
No
securities have been issued pursuant to the registration statement.
NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Use of Estimates
—The accompanying unaudited condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the related notes included in our Annual Report for the year ended December 31, 2018 filed with the SEC on March 14, 2019. The year-end condensed balance sheet was derived from our audited consolidated financial statements. Our unaudited interim condensed consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair statement of the condensed consolidated financial statements. The operating results for the six months ended June 30, 2019 are not necessarily indicative of the results expected for the full year ending December 31, 2019. Prior period figures have been reclassified, wherever necessary, to conform to current presentation. Significant estimates made in preparing these financial statements include (a) assumptions to calculate the fair values of financial instruments, warrants and equity instruments and other liabilities and the deferred tax asset valuation allowance and (b) the useful lives for depreciable and amortizable assets. Actual results could differ from those estimates.
Consolidation
—The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiary, GVR Trade, S.A. All significant intercompany balances and transactions have been eliminated.
Cash and Cash Equivalents
—We consider all liquid instruments purchased with a maturity of three months or less to be cash equivalents.
Concentration of Credit Risk
—We maintain bank accounts at
one
U.S. financial institution. The U.S. bank accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per account owner. GVR Trade S.A., our wholly owned Swiss-based subsidiary maintains checking accounts at one major national financial institution. Additionally, we maintain a checking account with a very minimal balance at one bank in South Korea, which is used to fund payroll and rent in South Korea. Management believes we are not exposed to significant credit risk due to the financial position of the depository institutions in which our deposits are held.
Restricted Cash
—Restricted cash as of June 30, 2019 and
December 31, 2018
consists of a
$211,000
pledged mutual fund account which is held as collateral against a letter of credit issued in May 2018 in connection with the lease of our corporate headquarters. See also Note 9 - Leases, for further details.
Investments
—Securities held-to-maturity: Management determines the appropriate classification of debt securities at the time of purchase and reevaluates such designation as of each balance sheet date. Investment/debt securities are classified as held-to-maturity when we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are stated at amortized cost, adjusted for amortization of premiums and accretion of discounts to maturity computed under the effective interest method. Such amortization is included in investment income. Interest on securities classified as held-to-maturity is included in interest and investment income.
When the fair value of an investment instrument classified as held-to-maturity is less than its amortized cost, management assesses whether or not: (i) we have the intent to sell the instrument or (ii) it is more likely than not that we will be required to sell the instrument before its anticipated recovery. If either of these conditions is met, we must recognize an other-than-temporary impairment for the difference between the instrument’s amortized cost basis and its fair value, and include such amounts in other income (expense).
For investment instruments that do not meet the above criteria and are not expected to be recovered at the amortized cost basis, the instrument is considered other-than-temporarily impaired. For these instruments, we separate the total impairment into the credit loss component and the amount of the loss related to other factors. In order to determine the amount of the credit loss, we calculate the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows management expects to recover. The discount rate is the effective interest rate implicit in the underlying instrument. The amount of the total other-than-temporary impairment related to credit loss is recognized in earnings and is included in other income (expense). The amount of the total other-than-temporary impairment related to other factors is recognized in other comprehensive income. For investment instruments that have other-than-temporary impairment recognized
through earnings, if through subsequent evaluation there is a significant increase in the cash flow expected, the difference between the amortized cost basis and the cash flows expected to be collected is accreted as interest income.
Fair Value of Financial Instruments
—We measure certain financial assets and liabilities at fair value based on the exit price notion, or price that would be received for an asset or paid to transfer a liability, in an orderly transaction between the market participants at the measurement date. The carrying amounts of our financial instruments, including cash equivalents, restricted cash, investments held-to-maturity, accounts payable, and accrued liabilities, approximate fair value due to their short maturities.
Accounts Receivable
—Trade accounts receivable are stated net of allowances for doubtful accounts. Management estimates the allowance for doubtful accounts based on review and analysis of specific customer balances that may not be collectible, customer payment history and any other customer-specific information that may impact ability to collect the receivable. Accounts are considered for write-off when they become past due and when it is determined that the probability of collection is remote. There was
no
allowance for doubtful accounts at
June 30, 2019
and
December 31, 2018
.
Property and Equipment
—Property and equipment consists of leasehold improvements associated with our corporate offices, software purchased during the normal course of business, equipment and office furniture and fixtures, all of which are recorded at cost. Depreciation and amortization is recorded using the straight-line method over the respective useful lives of the assets ranging from
three
to
five
years. Leasehold improvements are amortized over the shorter of lease term or useful life. Long-lived assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.
Intangible Assets, net
—Intangible assets are recorded at cost and amortized over the useful life. In the case of business combinations, intangible assets are recorded at fair value. At
June 30, 2019
and
December 31, 2018
, intangible assets, net, includes patents and a domain name and other intangible assets purchased as part of our acquisition of GVR, including customer relationships, technology and a trademark. Intangible assets are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. In certain cases, patents may expire or be abandoned as we no longer plan to pursue them. In such cases we write off the capitalized patent costs as patent abandonment costs which are included in research and development expenses.
Goodwill—
At
June 30, 2019
and
December 31, 2018
, goodwill represents the difference between the price paid to acquire GVR and the fair value of the assets acquired, net of assumed liabilities. We review goodwill for impairment annually and whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. As of January 1, 2019, we have adopted ASU No. 2017-04,
Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment
, which simplifies the accounting for goodwill impairments by eliminating step 2 from the goodwill impairment test.
Revenue Recognition
—We recognize revenue in accordance with the Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 606,
Revenue from Contracts with Customers.
Revenue is recognized upon the transfer of control of promised goods or services to the customers in an amount that reflects the consideration we expect to receive in exchange for those products or services. Revenue consists primarily of upfront non-refundable fees received in connection with filter design projects with customers and royalties. Our performance obligation is to design a licensable filter in accordance with customer specifications. The license of the completed design is considered part of this performance obligation as the design and licensing of the filter are highly interdependent. We recognize revenue over the course of the design development phase as our customers are able to benefit from our design services as they are provided, primarily by marketing the in-process design to their customers. We recognize revenue from our design services based on efforts expended to date. At the end of each reporting period, we reassess our measure of progress and adjust revenue when appropriate. We record the expenses related to these projects in the periods incurred and they are generally included in research and development expense.
In most cases, upfront non-refundable payments are recognized over a period of 12 to 18 months. Contracts generally include upfront non-refundable fees, intended to support our initial engineering product development efforts, and may include milestone payments based upon the successful completion of certain deliverables. Milestone payments represent variable consideration, and we use the "most likely amount" approach to determine the amount we ultimately expect to receive. At contract inception, we assess the likelihood of achieving milestones to estimate the total consideration we believe we will receive for our services.
Upon completion of design services, our customers retain a license over the completed design. The license will typically last for a minimum of two years, and in many cases for the life of the design. Royalties are sales-based, and we
recognize royalty revenue upon shipment, by our customer, of products that include our licensed design. Payment is generally due within 30 days.
We apply the practical expedients available in ASC 606 to not disclose information about 1) remaining performance obligations that have original expected durations of one year or less and 2) variable consideration that is a sales-based or usage-based royalty.
Research and Development
—Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with ASC Topic 730-10,
Research and Development
.
Operating Leases
—We lease office space and research facilities under operating leases. Certain lease agreements contain free or escalating rent payment provisions. As of January 1, 2019, we have adopted ASU No. 2016-02,
Leases (Topic 842)
as well as other clarifying and practical updates issued under
Leases (Topic 842)
applicable to us.
We determine if an arrangement is a lease at lease inception. Operating leases are included in right-of-use (“ROU”) lease assets, other current liabilities (current portion of lease obligations), and long term lease obligations on our balance sheets. ROU lease assets represent our right to use an underlying asset for the lease term and lease obligations represent our obligation to make lease payments arising from the lease. Operating ROU lease assets and obligations are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The ROU lease asset also includes any lease payments made and excludes lease incentives. We evaluate renewal options at lease inception and on an ongoing basis, and include renewal options which we are reasonably certain to exercise in our expected lease term when classifying leases and measuring lease liabilities. We allocate the consideration between lease and nonlease components and exclude nonlease components from our recognized lease assets and liabilities. See also
Recent Accounting Pronouncements
and Note 9 - Leases.
Minimum lease payments, including scheduled rent increases, are recognized as lease expenses on a straight-line basis over the applicable lease term. We recognize lease expenses within research and development and sales, marketing and administration expenses on a straight-line basis over the lease term.
We are not party to any leases for which we are the lessor.
Stock-Based Compensation
—We account for stock options in accordance with ASC Topic 718,
Compensation-Stock Compensation
. We use the Black-Scholes option valuation model for estimating fair value at the date of grant.
We account for restricted stock units issued at fair value, based on the market price of our stock on the date of grant, net of estimated forfeitures. Compensation expense is recognized for the portion of the award that is ultimately expected to vest over the period during which the recipient renders the required services to the Company generally using the straight-line single option method.
In the case of award modifications, we account for the modification in accordance with ASU No. 2017-09,
Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting
, whereby we recognize the effect of the modification in the period the award is modified.
As of January 1, 2019, we adopted ASU No. 2018-07,
Compensation-Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting
, which aligns the accounting of share-based payment awards issued to employees and non-employees. The adoption did not materially impact our condensed consolidated financial statements.
Stock-based compensation expense is included in research and development expenses and general and administrative expenses.
Earnings Per Share, or EPS
—EPS is computed in accordance with ASC Topic 260,
Earnings per Share
, and is calculated using the weighted average number of common shares outstanding during each period. Diluted EPS assumes the conversion, exercise or issuance of all potential common stock equivalents unless the effect is to reduce a loss or increase the income per share. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method), the exercise of warrants (using the if-converted method) and the vesting of restricted stock unit awards.
Income Taxes
—We account for income taxes in accordance with ASC Topic 740,
Income Taxes
, or ASC 740, which requires the recognition of deferred tax assets and liabilities for the future consequences of events that have been recognized in
our condensed consolidated financial statements or tax returns. The measurement of the deferred items is based on enacted tax laws. In the event the future consequences of differences between financial reporting bases and the tax bases of our assets and liabilities result in a deferred tax asset, ASC 740 requires an evaluation of the probability of being able to realize the future benefits indicated by such asset. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion or the entire deferred tax asset will not be realized. As part of the process of preparing our condensed consolidated financial statements, we are required to estimate our income tax expense in each of the jurisdictions in which we operate. We also assess temporary differences resulting from differing treatment of items for tax and accounting differences. We record a valuation allowance to reduce the deferred tax assets to the amount of future tax benefit that is more likely than not to be realized. For the period when we were organized as a limited liability company, we were treated as a partnership for federal and state income tax purposes under the entity classification domestic default rules. As of
June 30, 2019
and
December 31, 2018
,
no
liability for unrecognized tax benefits was required to be reported. We recognize interest and penalties related to income tax matters in income taxes, and there were
none
for the
three and six
months ended
June 30, 2019
and 2018.
We have filed, or are in the process of filing, tax returns that are subject to audit by the relevant tax authorities. Although the ultimate outcome would be unknown, we believe that any adjustments that may result from tax return audits are not likely to have a material, adverse effect on our condensed consolidated results of operations, financial position or cash flows.
Reclassifications
—Certain amounts in the condensed consolidated statement of cash flows for the six months ended June 30, 2018 have been reclassified to conform to current year presentation.
Foreign Currency Translation
—The Swiss Franc has been determined to be the functional currency for the net assets of our Swiss-based subsidiary. We translate the assets and liabilities to U.S. dollars at each reporting period using exchange rates in effect at the balance sheet date and record the effects of the foreign currency translation in accumulated other comprehensive loss in shareholders' equity. We translate the income and expenses to U.S. dollars at each reporting period using the average exchange rate in effect for the period and record the effects of the foreign currency translation as other comprehensive income (loss) in the condensed consolidated statements of comprehensive loss. Gains and losses resulting from foreign currency transactions are included in net loss in the condensed consolidated statements of comprehensive loss.
Recent Accounting Pronouncements
Leases—
In February 2016, the FASB issued ASU No. 2016-02,
Leases (Topic 842)
, which, among other things required the recognition of lease assets and lease liabilities on the balance sheet for substantially all leases, including operating leases. Expanded disclosures with additional qualitative and quantitative information are also required. ASU 2016-02 and its amendments are effective for interim and annual reporting periods beginning after December 15, 2018 and early adoption was permitted. The standard allows for two methods of transition, one of which allows for the guidance to be applied to all leases existing at the adoption date with a cumulative effect adjustment to the opening balance sheet of retained earnings. Under this transition approach, comparative periods presented in the financial statements remain under legacy lease guidance.
We adopted the standard, as well as certain practical expedients included therein, utilizing the optional transition method as of January 1, 2019. Therefore, we have not restated comparative periods in our 2019 financial statements and prior periods are not included in our leased properties footnote. The adoption did not have any cumulative adjustment impact on retained earnings. We elected the package of practical expedients permitted under the transition guidance, which allowed us to carry forward our historical assessments of: (1) whether contracts are or contain leases, (2) lease classification and (3) initial direct costs. In addition, we did not elect the hindsight practical expedient to determine the reasonably certain lease term for existing leases. We also elected a policy of not recording leases on our condensed consolidated balance sheets when the leases have a term of 12 months or less and we are not reasonably certain to elect an option to purchase the leased asset.
The adoption of the standard on January 1, 2019 caused us to recognize approximately
$3.0 million
in each, right-of-use assets and lease liabilities, in our condensed consolidated financial statements. The right-of-use asset balance reflects the impact of other liability amounts, specifically deferred rent, that has been effectively reclassified. The standard did not materially impact consolidated net income or liquidity.
NOTE 3—REVENUE RECOGNITION
We record contract assets and contract liabilities in connection with revenue recognized for filter design projects.
Contract Assets
- Contract assets, other than accounts receivable, consist of unbilled revenue and generally arise when revenue is recognized on a contract whose transaction price includes an estimate of variable consideration from milestone payments. We do not have material amounts of contract assets as we have relatively few contracts, only modest design service fees and a small number of contracts containing milestone payments. Contract asset balances are included in prepaid expenses and other current assets in our condensed consolidated balance sheets.
Contract Liabilities
- Our contract liabilities consist of customer deposits and deferred revenue. We classify contract liabilities as current or noncurrent based on the timing of when we expect to recognize revenue. Generally, our contract liabilities are expected to be recognized in one year or less. Customer deposits and deferred revenue are separately stated in our condensed consolidated balance sheets.
Summary of changes in contract assets and liabilities for the six months ended June 30, 2019 and 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30,
|
|
|
2019
|
|
2018
|
|
Contract assets
|
|
|
|
|
Contract assets, beginning
|
$
|
36,000
|
|
|
$
|
67,000
|
|
|
Contract assets at beginning of year transferred to accounts receivable
|
(36,000
|
)
|
|
(42,000
|
)
|
|
Contract assets recorded on contracts during the period
|
8,000
|
|
|
2,000
|
|
|
Contract assets, ending
|
$
|
8,000
|
|
|
$
|
27,000
|
|
|
|
|
|
|
|
Contract liabilities
|
|
|
|
|
Contract liabilities, beginning
|
$
|
271,000
|
|
|
$
|
146,000
|
|
|
Recognition of revenue included in beginning of year contract liabilities
|
(147,000
|
)
|
|
(124,000
|
)
|
|
Contract liabilities, net of revenue recognized on contracts during the period
|
63,000
|
|
|
217,000
|
|
|
Foreign currently translation
|
$
|
—
|
|
|
$
|
1,000
|
|
|
Contract liabilities, ending
|
$
|
187,000
|
|
|
$
|
240,000
|
|
The following table presents our disaggregated revenue by region and source:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
Revenue by geographic region:
|
|
|
|
|
|
|
|
|
United States
|
$
|
63,000
|
|
|
$
|
105,000
|
|
|
$
|
197,000
|
|
|
$
|
242,000
|
|
|
Switzerland
|
—
|
|
|
19,000
|
|
|
—
|
|
|
39,000
|
|
|
Total revenue
|
$
|
63,000
|
|
|
$
|
124,000
|
|
|
$
|
197,000
|
|
|
$
|
281,000
|
|
|
|
|
|
|
|
|
|
|
|
Revenue by source:
|
|
|
|
|
|
|
|
|
Design services
|
$
|
57,000
|
|
|
$
|
84,000
|
|
|
$
|
182,000
|
|
|
$
|
191,000
|
|
|
Royalties
|
6,000
|
|
|
40,000
|
|
|
15,000
|
|
|
90,000
|
|
|
Total revenue
|
$
|
63,000
|
|
|
$
|
124,000
|
|
|
$
|
197,000
|
|
|
$
|
281,000
|
|
NOTE 4—INVESTMENTS HELD-TO-MATURITY
We classify investments as held-to-maturity when we have the positive intent and ability to hold the securities to maturity.
During the six months ended June 30, 2019, we invested in commercial papers that were classified as investments held-to-maturity. As of June 30, 2019, both amortized cost value and fair value were
$4.5 million
with
zero
unrealized gain or loss. Remaining commercial papers totaling
$3.0 million
and
$1.5 million
mature in August and September of 2019, respectively. We did not recognize an other-than-temporary impairment or comprehensive gain or loss for the three and six months ended June 30, 2019.
We recorded interest and investment income of
$72,000
and
$98,000
for the three months ended June 30, 2019 and 2018, respectively, and
$178,000
and
$146,000
for the six months ended June 30, 2019 and 2018, respectively, associated with our cash and investment accounts.
NOTE 5—WARRANTS
From time to time, we have issued warrants to purchase shares of common stock. These warrants have been issued in connection with the financing transactions and consulting services. Our warrants are subject to standard anti-dilution provisions applicable to shares of our common stock.
In January 2018, we entered into an agreement with our founders to exchange warrants to purchase an aggregate of
249,999
shares of our common stock, with an exercise price of
$0.20
per share, for an amount of shares that would equal the number of shares they would have received if exercised under a cashless exercise. The effect of exchanging the warrants for shares of our common stock was considered a modification of the award which required us to record expense for the excess of the fair value of the common stock issued over the fair value of the exchanged warrants. On the date of the exchange the fair value of the warrants was determined to be
$1.6 million
and the fair value of the shares of common stock issued were
$1.6 million
. There was a difference in fair value of
$2,000
which was recorded to sales, marketing and administration expenses during the six months ended June 30, 2018.
No
expense was recorded in the six months ended June 30, 2019.
A roll-forward of warrant share activity from January 1, 2018 to
June 30, 2018
is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued and
Outstanding
Warrants as of
January 1, 2018
|
|
Warrants
Exercised/
Expired
|
|
Issued and Outstanding Warrants as of June 30, 2018
|
|
Bridge Warrants
|
249,999
|
|
|
(249,999
|
)
|
(1)
|
—
|
|
|
Consulting Warrants
|
12,223
|
|
|
(5,556
|
)
|
(2)
|
6,667
|
|
|
Financing Warrants
|
62,530
|
|
|
—
|
|
|
62,530
|
|
|
Underwriting Warrants
|
310,500
|
|
|
—
|
|
|
310,500
|
|
|
IR Consulting Warrants
|
6,000
|
|
|
—
|
|
|
6,000
|
|
|
Private Placement Warrants - 2016
|
891,063
|
|
|
(73,000
|
)
|
(3)
|
818,063
|
|
|
Underwriting Warrants - Public Offering 2016
|
122,175
|
|
|
—
|
|
|
122,175
|
|
|
Private Placement Warrants - September 2017
|
1,976,919
|
|
|
(10,600
|
)
|
(4)
|
1,966,319
|
|
|
Placement Agent Warrants
|
98,846
|
|
|
—
|
|
|
98,846
|
|
|
|
3,730,255
|
|
|
(339,155
|
)
|
|
3,391,100
|
|
(1) During the six months ended June 30, 2018, there were
249,999
warrants that were exchanged for
242,913
shares of common stock in an exchange transaction where the warrant holders exchanged the warrants for the same number of shares they would have been entitled to in a cashless exercise.
(2) During the six months ended June 30, 2018, there were
5,556
warrants that were exercised through a cashless exercise which netted
5,542
shares being issued.
(3) During the six months ended June 30, 2018, there were
73,000
warrants exercised for cash.
(4) During the six months ended June 30, 2018, there were
10,600
warrants exercised for cash.
A roll-forward of warrant share activity from January 1, 2019 to
June 30, 2019
is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise Price
|
|
Expiration Date
|
|
Issued and
Outstanding
Warrants as of
January 1, 2019
|
|
Warrants
Exercised/
Expired
|
|
Issued and Outstanding Warrants as of June 30, 2019
|
|
Consulting Warrants
|
$0.01
|
|
6/17/2020
|
|
6,667
|
|
|
—
|
|
|
6,667
|
|
|
Financing Warrants
|
$3.35
|
|
6/17/2020
|
|
62,530
|
|
|
—
|
|
|
62,530
|
|
|
Underwriting Warrants
|
$7.50
|
|
5/28/2019
|
|
310,500
|
|
|
(310,500
|
)
|
(1)
|
—
|
|
|
Private Placement Warrants - 2016
|
$2.86
|
|
4/25/2019
|
|
818,063
|
|
|
(818,063
|
)
|
(2)
|
—
|
|
|
Underwriting Warrants - Public Offering 2016
|
$4.25
|
|
9/9/2019
|
|
122,175
|
|
|
—
|
|
|
122,175
|
|
|
Private Placement Warrants - September 2017
|
$4.85
|
|
9/28/2020
|
|
1,966,319
|
|
|
—
|
|
|
1,966,319
|
|
|
Placement Agent Warrants
|
$4.85
|
|
9/28/2020
|
|
98,846
|
|
|
—
|
|
|
98,846
|
|
|
|
|
|
|
|
3,385,100
|
|
|
(1,128,563
|
)
|
|
2,256,537
|
|
|
|
|
|
(1)
|
During the six months ended
June 30, 2019
, there were
310,500
warrants that expired.
|
|
|
|
|
(2)
|
During the six months ended
June 30, 2019
, there were
485,000
warrants exercised for cash,
44,928
warrants that were exercised through a cashless exercise which netted
1,809
shares being issued and
288,135
warrants that expired.
|
NOTE 6—STOCKHOLDERS’ EQUITY AND LOSS PER SHARE
Common Stock
Pursuant to our amended and restated certificate of incorporation, we are authorized to issue
100,000,000
shares of common stock. Holders of our common stock are entitled to dividends as and when declared by the Board of Directors, subject to rights and holders of all classes of stock outstanding having priority rights to dividends. There have been no dividends declared to date. Each share of common stock is entitled to one vote.
On
March 27, 2018
, we completed the sale of
5,714,286
shares of common stock at a price of
$3.50
per share in an underwritten public offering. Gross proceeds were
$20.0 million
with net proceeds of
$18.4 million
after deducting underwriter fees and offering expenses. The shares were issued pursuant to a shelf registration statement that we filed with the SEC, which became effective in
May 2016
. On
April 6, 2018
, following exercise by the underwriter of its overallotment option, we sold an additional
857,142
shares at a price of
$3.50
, resulting in gross proceeds of
$3.0 million
and net proceeds of
$2.8 million
after deducting underwriter fees and offering expenses.
We have a Form S-3 universal shelf registration statement on file with the SEC. The universal shelf registration statement on Form S-3 permits us to sell, in one or more public offerings, shares of our common stock, shares of preferred stock or debt securities, or any combination of such securities and warrants to purchase securities, for proceeds in an aggregate amount of up to $50.0 million, subject to potential limitations on the amount of securities we may sell in any twelve-month period. The Form S-3 will expire in November 2021. No securities have been issued pursuant to the registration statement.
Preferred Stock
Pursuant to our amended and restated certificate of incorporation, we are authorized to issue
3,000,000
shares of preferred stock. The Board of Directors has the authority, without action by our stockholders, to designate and issue shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. To-date, no preferred shares have been issued.
Stock Repurchase Program
On November 26, 2018, we announced that our board of directors had authorized a program to repurchase up to
$4.0 million
of our common stock over a 12-month period, either in the open market or through privately negotiated transactions. As of December 31, 2018, we had repurchased approximately
$152,000
.
No
purchases were made in the three and six months ended June 30, 2019.
Loss Per Share
The following table presents the number of shares excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods below:
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30,
|
|
|
2019
|
|
2018
|
|
Common stock warrants
|
2,256,537
|
|
|
3,391,100
|
|
|
Common stock options
|
1,356,028
|
|
|
1,129,653
|
|
|
Non-vested restricted stock unit awards
|
2,654,141
|
|
|
2,162,547
|
|
|
Total shares excluded from net loss per share attributable to common stockholders
|
6,266,706
|
|
|
6,683,300
|
|
NOTE 7— STOCK-BASED COMPENSATION
2014 Omnibus Incentive Plan
In January 2014, our board of directors approved the 2014 Omnibus Incentive Plan and amended and restated the plan in March 2014. Our stockholders approved the Amended and Restated 2014 Omnibus Incentive Plan, or the 2014 Plan, in March 2014. Our 2014 Plan initially permitted for the issuance of equity-based instruments covering up to a total of
1,400,000
shares of common stock. Our board of directors and stockholders approved an increase of
1,300,000
shares in June 2016, an additional increase of
3,250,000
shares in June 2017, and an additional increase of
4,000,000
shares in June 2019, bringing the total shares allowed under the plan to
9,950,000
.
Option Valuation
We account for stock options in accordance with ASC Topic 718,
Compensation-Stock Compensation
. As of January 1, 2019, we adopted ASU No. 2018-07,
Compensation-Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting
, which aligns the accounting of share-based payment awards issued to employees and non-employees.
We use the Black-Scholes option valuation model for estimating fair value at the date of grant. Option forfeitures are estimated at the time of valuation and reduce expense ratably over the vesting period. This estimate will be adjusted periodically based on the extent to which actual option forfeitures differ, or are expected to differ, from the previous estimate, when it is material. The expected term used for options is the estimated period of time that options granted are expected to be outstanding. We have estimated the expected life of stock options using the “simplified” method, whereby, the expected life equals the arithmetic average of the vesting term and the original contractual term of the option due to our lack of sufficient historical data. Since our stock has not been publicly traded for a sufficiently long period of time, we are utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within our industry. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.
Stock Options
During the
three and six
months ended
June 30, 2018
, we granted incentive stock options for the purchase of
80,000
and
117,500
shares, respectively, of our common stock. The stock options have an exercise price range of
$4.12
per share to
$5.96
per share with a term of
10 years
. The stock options vest quarterly over
sixteen
quarters. For the three and six months ended June 30, 2018, the options granted had an aggregate grant date fair value of
$252,000
and
$393,000
, respectively, utilizing the Black-Scholes option valuation model.
During the
three and six
months ended
June 30, 2019
, we granted incentive stock options for the purchase of
62,000
and
102,000
shares, respectively, of our common stock. The stock options have an exercise price range of
$1.52
per share to
$3.15
per share with a term of
10 years
. The stock options vest quarterly over
sixteen
quarters. For the three and six months ended June 30, 2019, the options granted had an aggregate grant date fair value of
$120,000
and
$180,000
, respectively, utilizing the Black-Scholes option valuation model.
We estimated the fair value of stock options awarded during the
six
months ended June 30, 2019 and 2018 using the Black-Scholes option valuation model. The fair values of stock options granted for the periods were estimated using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
Stock Option Grants Awarded During the Six Months Ended June 30, 2019
|
|
Stock Option Grants Awarded During the Six Months Ended June 30, 2018
|
|
Stock Price
|
|
$1.52 to $3.15
|
|
$4.12 to $5.96
|
|
Dividend Yield
|
|
0.00%
|
|
0.00%
|
|
Expected Volatility
|
|
70%
|
|
70%
|
|
Risk-free interest rate
|
|
1.92% - 2.62%
|
|
2.50% - 2.89%
|
|
Expected Life
|
|
7 years
|
|
7 years
|
Stock-based compensation expense related to stock options was
$114,000
and
$123,000
for the three months ended June 30, 2019 and 2018, respectively, and
$210,000
and
$230,000
for the six months ended June 30, 2019 and 2018, respectively. For all stock options, we estimate forfeitures at the time of grant, and revise those estimates in subsequent periods if actual forfeitures differ from our estimates. We use historical data to estimate pre-vesting option forfeitures and record stock-based compensation expense only for those awards that are expected to vest. To the extent that actual forfeitures differ from our estimates, the difference is recorded as a cumulative adjustment in the period the estimates were revised. During the three and six months ended June 30, 2019 and June 30, 2018, we applied a forfeiture rate of
10%
and
6%
, respectively, which is reflected in our stock-based compensation expense related to stock options.
Stock Option Award Activity
The following is a summary of our stock option activity during the
six
months ended
June 30, 2019
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Grant Date
Fair Value
|
|
Weighted
Average
Remaining
Life In
Years
|
|
Outstanding, January 1, 2019
|
1,255,280
|
|
|
$
|
4.82
|
|
|
$
|
3.03
|
|
|
7.75
|
|
Granted
|
102,000
|
|
|
2.61
|
|
|
1.76
|
|
|
9.75
|
|
Exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Canceled / Forfeited
|
(1,252
|
)
|
|
4.62
|
|
|
2.79
|
|
|
—
|
|
Outstanding, June 30, 2019
|
1,356,028
|
|
|
$
|
4.65
|
|
|
$
|
2.93
|
|
|
7.43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Grant Date
Fair Value
|
|
Weighted
Average
Remaining
Life In
Years
|
|
Exercisable, January 1, 2019
|
843,019
|
|
|
$
|
5.02
|
|
|
$
|
3.13
|
|
|
7.23
|
|
Vested
|
84,887
|
|
|
4.17
|
|
|
2.63
|
|
|
7.88
|
|
Exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Canceled / Forfeited
|
(1,252
|
)
|
|
4.62
|
|
|
2.79
|
|
|
—
|
|
Exercisable, June 30, 2019
|
926,654
|
|
|
$
|
4.95
|
|
|
$
|
3.09
|
|
|
6.72
|
The following table presents information related to stock options outstanding and exercisable at
June 30, 2019
:
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
Options Exercisable
|
|
Exercise
Price
|
|
Outstanding
Number of
Options
|
|
Weighted
Average
Remaining
Life In
Years
|
|
Exercisable
Number
of Options
|
|
$1.52 – $3.15
|
|
263,183
|
|
|
6.70
|
|
122,641
|
|
|
$3.25 – $4.92
|
|
651,045
|
|
|
7.72
|
|
435,016
|
|
|
$5.01 – $6.00
|
|
281,500
|
|
|
5.52
|
|
227,435
|
|
|
$6.18 – $7.20
|
|
70,000
|
|
|
5.60
|
|
57,506
|
|
|
$7.54 – $7.80
|
|
67,800
|
|
|
5.66
|
|
61,556
|
|
|
$8.06 – $12.98
|
|
22,500
|
|
|
5.55
|
|
22,500
|
|
|
|
|
1,356,028
|
|
|
6.72
|
|
926,654
|
|
As of
June 30, 2019
, there was
$1.0 million
of unrecognized compensation expense related to unvested employee stock options, which is expected to be recognized over a weighted-average period of approximately
2.6 years
. The aggregate intrinsic values of outstanding stock options and vested stock options as of
June 30, 2019
were
$43,000
and
$22,000
, respectively, which represent options whose exercise price was less than the closing fair market value of our common stock on
June 30, 2019
of
$2.38
per share.
Restricted Stock Units Activity
We account for restricted stock units issued at fair value, based on the market price of our stock on the date of grant, net of estimated forfeitures. RSUs issued in connection with our employee incentive programs typically vest within 10 days of grant. All other RSUs, primarily issued as long term incentives, generally vest annually over three to four years.
During the three months ended June 30, 2019 and 2018, we recorded
$1.3 million
and
$1.5 million
, respectively, of stock-based compensation related to the restricted stock unit shares that had been issued to-date. During the six months ended June 30, 2019 and 2018, we recorded
$2.6 million
and
$2.3 million
, respectively, of stock-based compensation related to the restricted stock unit shares that had been issued to-date.
A summary of restricted stock unit activity for the
six
months ended
June 30, 2019
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Restricted Share
Units
|
|
Weighted-
Average
Grant-Date Fair
Value Per Share
|
|
Outstanding at January 1, 2019
|
1,921,594
|
|
|
$
|
4.78
|
|
|
Granted
|
1,311,917
|
|
|
3.05
|
|
|
Vested
|
(451,771
|
)
|
|
4.68
|
|
|
Forfeited
|
(127,599
|
)
|
|
4.36
|
|
|
Outstanding at June 30, 2019
|
2,654,141
|
|
|
$
|
3.74
|
|
As of
June 30, 2019
, there was
$6.9 million
of unrecognized compensation expense related to unvested restricted stock unit agreements which is expected to be recognized over a weighted-average period of approximately
2.3 years
. For restricted stock unit awards subject to graded vesting, we recognize compensation cost on a straight-line basis over the service period for the entire award.
Market-based Awards
In August 2016, we granted
250,000
market-based restricted stock units to an executive. The restricted stock units are subject to market-based vesting requirements, measured quarterly, based on the average of (a) the average high daily trading price of our common stock for each trading day during the last month of the applicable calendar quarter and (b) the average low daily trading price of our common stock for each trading day during the last month of the applicable calendar quarter, each as reported by The Nasdaq Stock Market, LLC. The restricted stock units are eligible to be earned on a quarterly basis based on a linear interpolation of the applicable share price, or in the case of a liquidation event, on the day of (or in connection with) such liquidation event based on the applicable transaction price. The share price on the date of issuance was
$5.06
per share.
In June 2019, the market-based award was modified to increase the number of restricted stock units to
500,000
and to decrease the applicable share price. Additionally, the performance period was extended to September 30, 2022. The share price on the date of modification was
$2.73
per share.
Once earned, the restricted stock units vest
50%
on the date such restricted stock units become earned and
50%
on
September 30, 2022
. We recognize compensation expense for restricted stock units with market conditions using a graded vesting model, based on the probability of the performance condition being met, net of estimated pre-vesting forfeitures. For the three months ended June 30, 2019 and 2018, we recognized
$1,000
and
$6,000
, respectively, and for the six months ended June 30, 2019 and 2018, we recognized
$7,000
and
$12,000
, respectively, of stock compensation expense in connection with this award, which is included in sales, marketing and administration expenses. The unamortized expense related to this award is
$146,000
and is expected to be recognized over
3.3
years.
Incentive Bonus Awards
We provide eligible employees, including executives, the opportunity to earn bonus awards upon achievement of predetermined performance goals and objectives. The purpose is to reward attainment of company goals and/or individual performance objectives, with award opportunities expressed as a percentage of base salary. Bonuses can be measured and paid quarterly and/or annually, and are paid in cash, equity or a combination of cash and equity, in the discretion of our compensation committee. If paid in the form of equity, the expense is included in the above disclosures for stock options or restricted stock units as applicable.
Total stock-based compensation recorded in the condensed consolidated statements of comprehensive loss is allocated as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2019
|
|
Three Months Ended June 30, 2018
|
|
Six Months Ended June 30, 2019
|
|
Six Months Ended June 30, 2018
|
|
Research and development
|
|
$
|
690,000
|
|
|
$
|
816,000
|
|
|
$
|
1,323,000
|
|
|
$
|
1,347,000
|
|
|
Sales, marketing and administration
|
|
767,000
|
|
|
811,000
|
|
|
1,488,000
|
|
|
1,243,000
|
|
|
Total stock-based compensation
|
|
$
|
1,457,000
|
|
|
$
|
1,627,000
|
|
|
$
|
2,811,000
|
|
|
$
|
2,590,000
|
|
NOTE 8—INCOME TAXES
Income tax for the three months ended June 30, 2019 and 2018 was an expense of
$0
and a benefit of
$8,000
, respectively. Income tax for the six months ended June 30, 2019 and 2018 was an expense of
$1,000
and benefit of
$8,000
, respectively. The effective tax rate for the three and six months ended June 30, 2019 and 2018 differed from the statutory rate primarily due to the valuation allowance recorded against the Company’s deferred tax assets.
NOTE 9— LEASES
We lease facilities under
two
non-cancelable operating leases. The leases expire between January 2022 and August 2024 and include renewal provisions for
two
to
five
years, provisions which require us to pay taxes, insurance, maintenance costs or provisions for minimum rent increases. We also lease facilities and equipment under short-term agreements for a period of
12 months
or less. All of the information presented below, with the exception of total lease costs, relates to our two non-cancelable operating leases.
One lease requires us to maintain a cash security deposit of
$50,000
and also a
$200,000
letter of credit in favor of the lessor. The letter of credit steps down
$50,000
at each anniversary date if there have been no monetary defaults. The letter of credit is secured by a pledge in favor of the issuing bank of a
$211,000
mutual fund account which is classified as restricted cash in our balance sheet.
Lease renewal options are at our discretion. No renewal options have been recognized in our right-of-use assets and lease liabilities as of
June 30, 2019
. Our lease agreements do not require material variable minimum lease payments, residual value guarantees or restrictive covenants.
The table below presents the operating lease assets and liabilities recognized on the condensed consolidated balance sheet as of
June 30, 2019
:
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Line Item
|
|
June 30, 2019
|
|
|
Operating lease assets
|
Operating lease right-of-use assets
|
|
$
|
2,786,000
|
|
|
Current operating lease liabilities
|
Operating lease liabilities, current
|
|
$
|
582,000
|
|
|
Noncurrent operating lease liabilities
|
Operating lease liabilities
|
|
$
|
2,372,000
|
|
|
Total operating lease liabilities
|
N/A
|
|
$
|
2,954,000
|
|
The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.
Our leases generally do not provide an implicit rate, and therefore we use our incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of the lease. We used a weighted average incremental borrowing rate of
4.75%
as of January 1, 2019 for operating leases that commenced prior to that date. The discount rates applied to each lease reflect our estimated incremental borrowing rate. This includes an assessment of our credit rating to determine the rate that we would have to pay to borrow, on a collateralized basis for a similar term, an amount equal to our lease payments in a similar economic environment.
The Company's weighted average remaining lease term and weighted average discount rate for operating leases as of
June 30, 2019
is shown below:
|
|
|
|
|
|
|
|
|
June 30, 2019
|
|
Weighted average remaining lease term (years)
|
|
4.70
|
|
Weighted average discount rate (%)
|
|
4.75
|
The table below reconciles the undiscounted cash flows for each of the first five years and total of the remaining years to the total operating lease liabilities recognized on the condensed consolidated balance sheets as of
June 30, 2019
:
|
|
|
|
|
|
|
|
|
|
|
June 30, 2019
|
|
|
July 1, 2019 through December 31, 2019
|
|
$
|
350,000
|
|
|
2020
|
|
726,000
|
|
|
2021
|
|
748,000
|
|
|
2022
|
|
557,000
|
|
|
2023
|
|
555,000
|
|
|
2024
|
|
376,000
|
|
|
Total minimum lease payments
|
|
3,312,000
|
|
|
Less: imputed interest
|
|
(358,000
|
)
|
|
Total operating lease liabilities
|
|
$
|
2,954,000
|
|
Operating lease costs were
$263,000
for the three months ended
June 30, 2019
, of which
$196,000
and
$67,000
are included in research and development expenses and sales, marketing and administration expenses, respectively. Operating lease costs were
$527,000
for the six months ended June 30, 2019, of which
$393,000
and
$134,000
are included in research and development expenses and sales, marketing and administration expenses, respectively. Prior to the adoption of ASC 842, we recorded rent expense for the three and six months ended June 30, 2018 of
$142,000
and
$284,000
, respectively, which was included in sales, marketing and administration expenses.
Cash paid for amounts included in the measurement of operating lease liabilities were
$269,000
for the six months ended
June 30, 2019
, and this amount is included in operating activities in the condensed consolidated statements of cash flows.
The future minimum obligations under operating leases in effect as of December 31, 2018 having a noncancelable term in excess of one year as determined prior to the adoption of ASU 842 are as follows:
|
|
|
|
|
|
|
|
|
December 31, 2018
|
|
2019
|
$
|
658,000
|
|
|
2020
|
726,000
|
|
|
2021
|
748,000
|
|
|
2022
|
557,000
|
|
|
2023
|
555,000
|
|
|
2024
|
376,000
|
|
|
Future minimum obligations
|
$
|
3,620,000
|
|
NOTE 10— COMMITMENTS AND CONTINGENCIES
Legal Proceedings
—
W
e are not party to any legal proceedings. We may, from time to time, be party to litigation and subject to claims incident to the ordinary course of business. As our growth continues, we may become party to an increasing number of litigation matters and claims. The outcome of litigation and claims cannot be predicted with certainty, and the resolution of any future matters could materially affect our future financial position, results of operations or cash flows.
Legal fees and other costs associated with legal proceedings are expensed as incurred. We assess, in conjunction with our legal counsel, the need to record a liability for litigation and contingencies. Litigation accruals are recorded when and if it is determined that a loss related matter is both probable and reasonably estimable. Material loss contingencies that are reasonably possible of occurrence, if any, are subject to disclosure. We evaluate developments in legal proceedings and other matters on a quarterly basis. As of June 30, 2019 and 2018, there was
no
litigation or contingency with at least a reasonable possibility of a material loss.
No
losses have been recorded during the
three and six
months ended June 30, 2019 and 2018, respectively, with respect to litigation or loss contingencies.
Intellectual Property Indemnities
—We indemnify certain customers and manufacturers against liability arising from third-party claims of intellectual property rights infringement related to our products. These indemnities may appear in license agreements, development agreements and manufacturing agreements, may not be limited in amount or duration and generally survive the expiration date of the contract. Given that the amount of any potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, we are unable to determine the maximum amount of losses that we could incur related to such indemnifications.
Director and Officer Indemnities and Contractual Guarantees
—We have entered into indemnification agreements with our directors and executive officers, which require us to indemnify such individuals to the fullest extent permitted by Delaware law. Our indemnification obligations under such agreements are not limited in amount or duration. Certain costs incurred in connection with such indemnifications may be recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities.
We have also entered into severance and change in control agreements with certain of our executives. These agreements provide for the payment of specific compensation benefits to such executives upon the termination of their employment with us.
Guarantees and Indemnities
—In the normal course of business, we are occasionally required to undertake indemnification for which we may be required to make future payments under specific circumstances. We review our exposure under such obligations no less than annually, or more frequently as required. The amount of any potential liabilities related to such obligations cannot be accurately determined until a formal claim is filed. Historically, any such amounts that become payable have not had a material negative effect on our business, financial condition or results of operations. We maintain general and product liability insurance which may provide a source of recovery to us in the event of an indemnification claim.
NOTE 11— SUBSEQUENT EVENTS
On July 31, 2019, we entered into a securities purchase agreement with Murata Electronics North America, Inc., an affiliate of Murata Manufacturing Co., Ltd., which agreement was subsequently joined by additional institutional and individual accredited investors, to raise gross proceeds of approximately
$10.0 million
in a private placement of common stock at a per-share price of
$2.53
. The initial closing of the Offering, for approximately
$3.0 million
, is scheduled to occur on or about August 12, 2019, subject to satisfaction of customary closing conditions. The closing of Murata’s investment for
$7.0 million
is subject to the execution of a definitive multi-year commercial agreement that provides Murata with rights to multiple designs utilizing the Company’s technology, as well as applicable governmental approval. We expect to use the proceeds from
the offering to continue our product development efforts and business development activities, including those that will be the subject of our commercial agreement with Murata, and for general and administrative purposes.